These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8927398)
1. Four-drug initial therapy for TB is standard treatment. Brennan PJ; MacGregor RR Pa Med; 1996 Jan; 99(1):18-9. PubMed ID: 8927398 [No Abstract] [Full Text] [Related]
2. [Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)]. Utkin VV Probl Tuberk; 1978 Oct; (10):23-8. PubMed ID: 714901 [No Abstract] [Full Text] [Related]
3. [Rifampin in the treatment of children with newly detected intrathoracic tuberculosis]. Gvasaliia T Probl Tuberk; 1984 Apr; (4):46-50. PubMed ID: 6610872 [No Abstract] [Full Text] [Related]
6. Completing tuberculosis prophylaxis in jail: targeting treatment and a comparison of rifampin/pyrazinamide with isoniazid regimens. Lambert LA; Ijaz K; Navin TR Int J Tuberc Lung Dis; 2005 Feb; 9(2):230; author reply 230-1. PubMed ID: 15732748 [No Abstract] [Full Text] [Related]
7. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance (Report 2) (author's transl)]. Baba H; Azuma Y Kekkaku; 1977 Dec; 52(12):619-26. PubMed ID: 604603 [No Abstract] [Full Text] [Related]
8. Rationale and experimental data in support of the use of a fixed-triple combination of isoniazid, rifampicin and pyrazinamide in the chemotherapy of tuberculosis. Acocella G G Ital Chemioter; 1987; 34(1-3):3-5. PubMed ID: 3504412 [No Abstract] [Full Text] [Related]
9. [Our experience in short-course treatment of tuberculosis. Results obtained by using therapeutic regimens of 6 to 8 months]. Ben Kheder A; Chabbou A; Zakhama B; Zaimi M; el Gharbi T; el Mekki L; el Gharbi B Bull Int Union Tuberc; 1985; 60(1-2):26-8. PubMed ID: 4074968 [No Abstract] [Full Text] [Related]
11. [Remote results of treatment of cutaneous tuberculosis by a combined method using streptomycin, isoniazid and P-aminosalicylic acid]. Arkuszewska C; Olszewska Z Przegl Dermatol; 1979; 66(5):561-6. PubMed ID: 523695 [No Abstract] [Full Text] [Related]
14. [A study on short-course chemotherapy for pulmonary tuberculosis. (Report I) (author's transl)]. Yamamoto K; Aizawa H; Sasaoka M; Suzuki T; Yamaguchi W Kekkaku; 1977 Feb; 52(2):39-45. PubMed ID: 853586 [No Abstract] [Full Text] [Related]
15. [Microbiological evaluation of the abacillary state in the combined therapy of destructive pulmonary tuberculosis in experimental animals]. Kunichan AD; Nemsadze MN Probl Tuberk; 1982 Nov; (11):62-5. PubMed ID: 7156108 [No Abstract] [Full Text] [Related]
17. Short course chemotherapy in tuberculous meningitis: a pilot trial. Sunakorn P; Pongparit S; Wongrung S J Med Assoc Thai; 1980 Jun; 63(6):340-5. PubMed ID: 7410983 [No Abstract] [Full Text] [Related]
18. Is the treatment of WHO category I tuberculosis with 2HRZE/6HE a defensible practice? Long R; Scalcini M Int J Tuberc Lung Dis; 1999 Sep; 3(9):747-8. PubMed ID: 10488879 [No Abstract] [Full Text] [Related]
19. [Activity of intermittently administered rifampicin and cyclopentyl rifamycin (or DL473) on experimental tuberculosis in the mouse]. Truffot-Pernot C; Grosset J; Bismuth R; Lecoeur H Rev Fr Mal Respir; 1983; 11(6):875-82. PubMed ID: 6669798 [TBL] [Abstract][Full Text] [Related]
20. [Drug therapy of urogenital tuberculosis]. König K Urologe; 1970 Jan; 9(1):44. PubMed ID: 5461516 [No Abstract] [Full Text] [Related] [Next] [New Search]